net dbt
near term outlook strong head
rais estim remain top pick
report adj ep consensu
beat driven primarili lower medic loss ratio despit flu lower
sg dcp day claim payabl day sequenti underscor
qualiti beat guidanc rais welcom sign given elev flu
essenti rais beat seem conserv meanwhil manag
remain bullish growth prospect expect upsid year goe
rais ep estim
strong perform higher visibl antm growth prospect
unchang po base ep estim vs prior estimate
reiter buy rate remain top pick
color guidanc seem conserv
beat rais guidanc note
benefit medicaid retroact payment expect receiv
move addit guidanc assum flu season would wors
normal march march flu trend abat help number
someth would expect flow rest year despit
compon gener indic ep better expect strong
medic management overal guidanc appear conserv expect beats/rais
fischbeck focu need buy someth
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu antm organ growth capabl whether
compani need pursu large-scal strateg peer compani
bullish long term growth prospect commerci govern
busi see growth prospect ingeniorx appreci
street howev question remain whether compani need pursu larg deal
order remain competit evolv marketplac post cvs/aet
ci/esrx deal lay case think well posit grow
stand-alone entiti walk strateg may make sens follow
overal dont see near term need pursu larg vertic deal long
execut next year plan
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
one largest manag care
organ offer
commerci larg small employ medicar
medicaid individu market compani
oper cross shield plan
buy rate reflect view
valuat overli discount hc reform risk
undervalu compani growth profil
fischbeck focu deal deal
fischbeck focu section choos theme explor detail either
respons recent investor question unexpect develop
quarter quarter focu antm organ growth capabl whether
compani need pursu large-scal strateg peer compani
bullish long term growth prospect commerci govern
busi see growth prospect ingeniorx appreci
street howev question remain whether compani need pursu larg
deal order remain competit evolv marketplac post cvs/aet
ci/esrx deal lay case think well posit grow
stand-alone entiti walk strateg may make sens follow
overal dont see near term need pursu larg vertic deal long
execut next year plan
reset year revenu growth
larg reset year revenu growth return health insur fee
hif headwind compani exit half exchang busi
quarter increas oper revenu guidanc million
billion addit america choic partial off-set lower expect
enrol local group insur product new guidanc impli year
year revenu growth well mid/high singl digit revenu growth wed
expect mco achiev long term meanwhil estim core revenu
growth exclud america choic deal year year
start reacceler
commerci growth busi scale help
gener expect commerci membership industri flat
next year compani character commerci busi
cash cow use fund growth excit opportun meanwhil
shift risk aso creat industri headwind growth net risk price
grow aso price grow commerci revenu grow low
singl digit industri go get growth commerci
busi need gain share drive increas specialti penetr
mix shift aso lt headwind
talk transit local group fulli insur membership
aso emphas convers happen slower rate
previou year kaiser chart demonstr dynam howev
still shift toward aso repres lt headwind mco
larg commerci busi
exhibit percent cover worker partial complet self-fund plan firm size
everi commerci risk member shift aso ep
standard risk contract price pmpm yield profit margin one
member would therefor gener annual premium revenu
oper profit see exampl one member switch risk
aso could creat materi headwind
show analysi potenti ep impact mix shift
commerci risk commerci aso hif return
temporari suspens overal estim everi antm
commerci risk member shift aso would drag ep
commerci risk member shift aso
commerci risk member shift aso
ep impact mix shift
negoti rate health care provid discount vari depend
insur local market share high local market share provid commerci insur
better negoti leverag provid doctor hospit etc doctor hospit
give insur repres volum much better rate insur
repres volum price differenti larg health plan
small health plan vari wide percentag point differ
industry-lead market share state allow obtain
strong provid discount show antm commerci market share state
present investor day number still direct correct
although time compani grown larg group nation aso
busi lose market share individu may make certain state
exhibit antm commerci market share state
sg leverag lower input cost per member
larg manag care compani achiev sg leverag spread
technolog invest clinic program call center mainten cost
broad nation membership base exampl econom invest system
significantli better compani million member compani
shown industry-lead sg leverag help support
compani strong earn growth trajectori
plan segment aet ci
exclud medicar part medicar supplement dental enrol
ad back qualiti expens report medic cost
post minimum floor world scale becom increasingli import
gross margin cap net margin grown lower sg meanwhil
compani scale low unit cost offer attract product
consum increas enrol indirect benefit higher enrol add
profit compani make margin higher revenu base also allow
plan increas sg leverag boost margin spread fix cost across
look grow
lower commerci risk membership outlook new guidanc
compani character price environ competit ration instead
issu provid full suit buydown opportun help keep
custom risk product respons roll initi better
segment busi respond chang market dynam quickli
expect grow membership remaind given scale
advantag look well posit
strong specialti offer increasingli differenti commerci market
plan expand breadth self-fund custom relationship
improv specialti penetr product dental vision compani
end commerci dental penetr slightli less vision
penetr rate around note penetr rate
improv meaning last sever year bear watch estim
everi ad per aso member per month repres addit specialti
product could add ep
tabl ep impact increas specialti penetr
tabl ep impact increas specialti penetr
ep impact increas specialti penetr
medicar start grow faster peer pbm boost
antm medicar growth gener lag peer compani market share
well commerci market share part done purpos
compani exit unprofit counti close ineffici ppo plan
turn around complet compani grown faster industri
gain share past two year
market share time
current control individu medicar advantag market
year end driven compani acquisit america choic
close ad live central florida
current control group market market share
remain rel consist last year although profit
competitor gener done better note larg y/i declin
antm group market share due atnm discontinu
current control stand-alone prescript drug pdp market
compani gener lost share handicap esrx contract other
gain share
star improv help growth
recent indic expect grow doubl digit compani
improv star rate help compani achiev remind compani
star higher get extra boost rate give flexibl
improv margin add extra benefit acceler membership growth
seen steadi improv star rate past year recent
improv star member star rate plan
new pbm drive gener save help reacceler growth
part antm issu medicar weak pharmaci cost structur driven pbm
agreement esrx howev new pharmaci contract
antm cost structur result growth meaning improv
emphas save expect new pbm structur
begin transit member expect fulli transit
membership share transit cost bring
member new platform believ cost
materi time result would expect see part save
full benefit seen rest
pass back custom estim translat ep impact
assum ep growth would add ep
tabl ep impact gross pharmaci save
posit medicar product
antm new pbm help drive strong growth across product especi medicar
given senior tend higher drug util note analysi antm part
price vs show sever disadvantag compani pass
pharmaci save custom abl grow medicar part
first time year meanwhil one main benefit mco give away
enrolle cheap part plan see reduct cost
provid part allow compani provid addit benefit senior
margin turn allow compani acceler
membership growth
gain share achiev strong margin estim could drive
compani ep
meanwhil gain signific share stand-alone pdp achiev strong
margin estim pdp could drive compani ep
tabl potenti exposur stand-alone pdp
tabl potenti exposur stand-alone pdp
oper mani state medicaid perform vari state
state howev gener high visibl stabl oper perform
view one best run medicaid mco today think medicaid
busi like oper within target margin rang
strong track record win new busi look well posit
capit upcom rfp pipelin expect medicaid rfp next
month rfp pipelin
notabl success partner cross health plan
provid group win medicaid busi state alreadi
cross licens compani launch new medicaid joint ventur
arkansa provid coalit repres antm medicaid allianc
agreement initi focu provid behavior health manag
servic launch full-risk health manag product next year
meanwhil antm partnership cross shield minnesota expect
go live fall serv approxim medicaid dual member year
end partnership involv risk share arrang take
revenu claim admin meanwhil charg bcb minnesota
administr fee membership final blue brand
product build antm brand awar
also recent reprocur florida medicaid busi base region
analysi think maintain rel stabl membership base earn
exposur new contract
recal medicaid live manag care less half
medicaid spend manag still substanti opportun
mco grow particularli higher acuiti popul
state wide variat medicaid manag care penetr rate state
tennesse hawaii iowa nebraska new jersey kansa outsourc
medicaid program manag care state outsourc major
medicaid live manag care keep certain popul type fee servic
exampl indiana outsourc total medicaid live manag care
abd live manag care final state north carolina
medicaid manag care program repres signific rfp
opportun state seek save money outsourc medicaid mco
view particularli well posit medicaid growth given strong past
perform histori save money state
tabl medicaid penetr popul type state
district columbia
tabl medicaid penetr popul type state
new pbm agreement help medicaid
similar cost save help grow part busi believ
new pharmaci agreement help win medicaid busi note
highest win percentag rfp among peer bid
mani rfp compani compani need
confid program structur way earn appropri
return compani cost structur improv new pharmaci agreement
estim potenti rfp fit antm return criteria
would expect see bid win rfp
final compani believ opportun build ingeniorx intern
pbm sell servic extern underappreci opportun compani
believ target non-profit blue potenti custom note
sell radiolog behavior specialti servic alongsid pbm essenti
replic optum given success
medicaid jv track record work mani compani could
win new busi current anyth built model
would upsid growth execut
deal might make sens follow
potenti rational pursu large-scal transform
mco/pbm/retail pharmaci market would gain capabl
current case pbm compani believ alreadi skill set
build competit offer meanwhil compani gener see
need buy capit intens provid vertic integr although
physician group clinic market believ signific local
scale mean alway align provid favor term without
invest capit gener believ antm view merit
compani could uniqu aspect extrem dens local share
second potenti reason align anoth larg healthcar compani would
cash flow chart left show analysi
use prior year net incom proxi ci aet
meanwhil estim unh base ocf capital-expenditure guidanc expect
gener approxim slightli ci aet
goliath current landscap estim compani
gener driven high optum busi base
estim four compani trade yield
meanwhil chart right show assum
cvs/aet ci/esrx success close merger notabl would
gener significantli averag new mco/pbm landscap unclear
next must capabl consum engag medic
manag etc compani need acquir quickli gain maintain
advantag antm rel smaller could make difficult compani
compet deal capabl
chart
chart
note one area potenti upsid analysi would compani
conserv grow ingeniorx current estim pbm
servic good busi nevertheless even success like would
close gap ci rather catapult top view posit
next potenti arm race might best argument larger
conclus transform need growth
overal reset year top line growth compani appear well
posit see reacceler growth across three busi line antm
commerci busi saw membership declin appear put place
action stabl reacceler growth fast grow segment
begun improv growth trajectori star improv
help growth medicaid rfp pipelin strong look well posit
meanwhil three busi see improv growth prospect
new pharmaci agreement kick pass back save
custom final ingeniorx could turn extern growth engin compani
help growth top line compani overal believ
growth trajectori next year look attract stand-alone basi give
compani time decid whether strateg tie-up necessari take
overview guidanc
histori conservat
note histor provid conserv guidanc beat
rais throughout year fact rais guidanc vs
consensu beat impli conservat expect upsid year goe
tabl initi guidanc compar actual result
adj ep rais
increas adjust ep guidanc greater
impli year year growth least compani re-affirmed long term
ep growth higher end single-digit double-digit growth rang
oper revenu guidanc also rais billion billion
addit america choic partial off-set lower expect enrol
self-fund membership expect million
previou guidanc fully-insur membership guidanc continu
million overal net enrol expect million midpoint
million impli rel flat growth year year note addit
america choic expect member end year
four-star plan
sg outlook lower basi point midpoint
expect /- basi point /- basi point
respect outlook decreas attribut better-than-expect
medic cost perform
meanwhil re-affirmed oper cash flow cost trend outlook compani
still expect repurchas share billion end
amort
po base ep estim premium histor
averag justifi believ rel high potenti upsid
estim stand-alone risk upsid better-than-expect
enrol growth stronger growth medicar advantag time enhanc
buyback interest rate hike well lt benefit new pbm agreement
risk downsid worse-than-expect membership growth rise cost trend
greater-than expect hc reform disrupt
kevin fischbeck cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us facil hospit manag healthcar coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
